[Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
Identifieur interne : 001623 ( PubMed/Corpus ); précédent : 001622; suivant : 001624[Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
Auteurs : K. Masmoudi ; G. Decocq ; E. Chetaille ; A. Rosa ; J P Mizon ; M. AndréjakSource :
- Therapie [ 0040-5957 ]
English descriptors
- KwdEn :
- Acute Disease, Aged, Antidepressive Agents, Second-Generation (adverse effects), Antidepressive Agents, Second-Generation (therapeutic use), Dyskinesia, Drug-Induced (etiology), Female, Flushing (drug therapy), Humans, Middle Aged, Parkinson Disease, Secondary (chemically induced), Sulpiride (adverse effects), Sulpiride (analogs & derivatives), Sulpiride (therapeutic use).
- MESH :
- chemical , adverse effects : Antidepressive Agents, Second-Generation, Sulpiride.
- chemical , analogs & derivatives : Sulpiride.
- chemical , therapeutic use : Antidepressive Agents, Second-Generation, Sulpiride.
- chemically induced : Parkinson Disease, Secondary.
- drug therapy : Flushing.
- etiology : Dyskinesia, Drug-Induced.
- Acute Disease, Aged, Female, Humans, Middle Aged.
Abstract
Veralipride is a substituted benzamide which is used for the treatment of menopausal hot flushes. We report five cases with extrapyramidal disorders associated to a treatment with this drug for which the neuroleptic activity resulting from an interaction with D2 receptors is not always known by prescribers. One case consisted of acute dyskinesias and four of parkinsonian syndromes, one of these being associated with tardive dyskinesia. In these four cases, dosing recommendations were not respected.
PubMed: 8571284
Links to Exploration step
pubmed:8571284Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].</title><author><name sortKey="Masmoudi, K" sort="Masmoudi, K" uniqKey="Masmoudi K" first="K" last="Masmoudi">K. Masmoudi</name><affiliation><nlm:affiliation>Service de Neurologie, CHU d'Amiens, Hôpital Nord et Sud, France.</nlm:affiliation></affiliation></author><author><name sortKey="Decocq, G" sort="Decocq, G" uniqKey="Decocq G" first="G" last="Decocq">G. Decocq</name></author><author><name sortKey="Chetaille, E" sort="Chetaille, E" uniqKey="Chetaille E" first="E" last="Chetaille">E. Chetaille</name></author><author><name sortKey="Rosa, A" sort="Rosa, A" uniqKey="Rosa A" first="A" last="Rosa">A. Rosa</name></author><author><name sortKey="Mizon, J P" sort="Mizon, J P" uniqKey="Mizon J" first="J P" last="Mizon">J P Mizon</name></author><author><name sortKey="Andrejak, M" sort="Andrejak, M" uniqKey="Andrejak M" first="M" last="Andréjak">M. Andréjak</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1995 Sep-Oct</MedlineDate></PubDate></date><idno type="RBID">pubmed:8571284</idno><idno type="pmid">8571284</idno><idno type="wicri:Area/PubMed/Corpus">001623</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001623</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].</title><author><name sortKey="Masmoudi, K" sort="Masmoudi, K" uniqKey="Masmoudi K" first="K" last="Masmoudi">K. Masmoudi</name><affiliation><nlm:affiliation>Service de Neurologie, CHU d'Amiens, Hôpital Nord et Sud, France.</nlm:affiliation></affiliation></author><author><name sortKey="Decocq, G" sort="Decocq, G" uniqKey="Decocq G" first="G" last="Decocq">G. Decocq</name></author><author><name sortKey="Chetaille, E" sort="Chetaille, E" uniqKey="Chetaille E" first="E" last="Chetaille">E. Chetaille</name></author><author><name sortKey="Rosa, A" sort="Rosa, A" uniqKey="Rosa A" first="A" last="Rosa">A. Rosa</name></author><author><name sortKey="Mizon, J P" sort="Mizon, J P" uniqKey="Mizon J" first="J P" last="Mizon">J P Mizon</name></author><author><name sortKey="Andrejak, M" sort="Andrejak, M" uniqKey="Andrejak M" first="M" last="Andréjak">M. Andréjak</name></author></analytic><series><title level="j">Therapie</title><idno type="ISSN">0040-5957</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Aged</term><term>Antidepressive Agents, Second-Generation (adverse effects)</term><term>Antidepressive Agents, Second-Generation (therapeutic use)</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Female</term><term>Flushing (drug therapy)</term><term>Humans</term><term>Middle Aged</term><term>Parkinson Disease, Secondary (chemically induced)</term><term>Sulpiride (adverse effects)</term><term>Sulpiride (analogs & derivatives)</term><term>Sulpiride (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antidepressive Agents, Second-Generation</term><term>Sulpiride</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Sulpiride</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antidepressive Agents, Second-Generation</term><term>Sulpiride</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Flushing</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Aged</term><term>Female</term><term>Humans</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Veralipride is a substituted benzamide which is used for the treatment of menopausal hot flushes. We report five cases with extrapyramidal disorders associated to a treatment with this drug for which the neuroleptic activity resulting from an interaction with D2 receptors is not always known by prescribers. One case consisted of acute dyskinesias and four of parkinsonian syndromes, one of these being associated with tardive dyskinesia. In these four cases, dosing recommendations were not respected.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8571284</PMID><DateCreated><Year>1996</Year><Month>03</Month><Day>07</Day></DateCreated><DateCompleted><Year>1996</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0040-5957</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><Issue>5</Issue><PubDate><MedlineDate>1995 Sep-Oct</MedlineDate></PubDate></JournalIssue><Title>Therapie</Title><ISOAbbreviation>Therapie</ISOAbbreviation></Journal><ArticleTitle>[Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].</ArticleTitle><Pagination><MedlinePgn>451-4</MedlinePgn></Pagination><Abstract><AbstractText>Veralipride is a substituted benzamide which is used for the treatment of menopausal hot flushes. We report five cases with extrapyramidal disorders associated to a treatment with this drug for which the neuroleptic activity resulting from an interaction with D2 receptors is not always known by prescribers. One case consisted of acute dyskinesias and four of parkinsonian syndromes, one of these being associated with tardive dyskinesia. In these four cases, dosing recommendations were not respected.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Masmoudi</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Service de Neurologie, CHU d'Amiens, Hôpital Nord et Sud, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decocq</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Chetaille</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mizon</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Andréjak</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Troubles extrapyramidaux induits par le véralipride (Agréal). A propos de cinq observations.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Therapie</MedlineTA><NlmUniqueID>0420544</NlmUniqueID><ISSNLinking>0040-5957</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018687">Antidepressive Agents, Second-Generation</NameOfSubstance></Chemical><Chemical><RegistryNumber>7MNE9M8287</RegistryNumber><NameOfSubstance UI="D013469">Sulpiride</NameOfSubstance></Chemical><Chemical><RegistryNumber>S7064109UD</RegistryNumber><NameOfSubstance UI="C027429">veralipride</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018687" MajorTopicYN="N">Antidepressive Agents, Second-Generation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004409" MajorTopicYN="N">Dyskinesia, Drug-Induced</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005483" MajorTopicYN="N">Flushing</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010302" MajorTopicYN="N">Parkinson Disease, Secondary</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013469" MajorTopicYN="N">Sulpiride</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8571284</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001623 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001623 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:8571284
|texte= [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:8571284" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |